𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Harnessing T-lymphocytes for human cancer immunotherapy

✍ Scribed by Yashar Hirshaut; Susan F. Slovin

Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
885 KB
Volume
56
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Potential of human Ξ³Ξ΄ T lymphocytes for
Potential of human Ξ³Ξ΄ T lymphocytes for immunotherapy of cancer
✍ Dieter Kabelitz; Daniela Wesch; Elke Pitters; Margot ZΓΆller πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 92 KB

## Abstract T lymphocytes are classified into 2 subsets based on their T‐cell receptor (TCR) expression. The vast majority of T cells expresses an Ξ±Ξ² TCR heterodimer. These Ξ±Ξ² T cells recognize antigenic peptides presented by MHC class I (for CD8^+^ T cells) or MHC class II molecules (for CD4^+^ T

Adoptive immunotherapy for advanced canc
Adoptive immunotherapy for advanced cancer patients using in vitro activated cytotoxic T lymphocytes
✍ Soda, Hiroaki; Koda, Keiji; Yasutomi, Jun; Oda, Kenji; Takiguchi, Nobuhiro; Sait πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 219 KB πŸ‘ 2 views

## Background and Objectives: We evaluated the clinical efficacy of adoptive immunotherapy using in vitro activated cytotoxic T lymphocytes (CTL) in the treatment of patients with advanced cancer. Methods: CTL were induced with the mixed lymphocyte and tumor cell culture method, in which lymphocyte